2022 - Research.com Medicine in Singapore Leader Award
His main research concerns Internal medicine, Cardioprotection, Reperfusion injury, Cardiology and Ischemic preconditioning. His Internal medicine research incorporates themes from Endocrinology and Phosphorylation. His Cardioprotection study combines topics from a wide range of disciplines, such as Diabetes mellitus, Cardiovascular agent and Intensive care medicine.
His Reperfusion injury research incorporates elements of Reperfusion therapy, Protein kinase B and Mitochondrial permeability transition pore. His Cardiology study deals with Magnetic resonance imaging intersecting with Hypertrophic cardiomyopathy, Cardiomyopathy and Angina. His Ischemic preconditioning research is multidisciplinary, incorporating perspectives in Anesthesia, Clinical trial, Heart metabolism, Myocardial Reperfusion Injury and Kinase.
Derek J. Hausenloy spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Cardioprotection and Ischemia. Internal medicine is a component of his Percutaneous coronary intervention, Reperfusion injury, Ischemic preconditioning and Heart failure studies. His biological study spans a wide range of topics, including Acute kidney injury and Anesthesia.
His studies in Cardiology integrate themes in fields like Randomized controlled trial, Surgery, Magnetic resonance imaging and Cause of death. His work in the fields of Myocardial infarction, such as Infarction, Ventricular remodeling and ST segment, intersects with other areas such as In patient. His Cardioprotection study incorporates themes from Protein kinase B, Disease, Mitochondrial permeability transition pore, Neuroscience and Pharmacology.
His primary areas of investigation include Internal medicine, Myocardial infarction, Cardiology, Cardioprotection and Heart failure. His work deals with themes such as Inflammation, Interquartile range, Incidence and Ischemia, which intersect with Myocardial infarction. Derek J. Hausenloy works in the field of Ischemia, namely Reperfusion injury.
His Cardiology research focuses on Magnetic resonance imaging and how it connects with Area at risk and Edema. His studies deal with areas such as Oxidative stress, Intensive care medicine, Mitochondrial permeability transition pore, Pharmacology and Mitochondrion as well as Cardioprotection. Derek J. Hausenloy combines subjects such as Stroke, Disease, Review article and Neuroscience with his study of Heart failure.
His scientific interests lie mostly in Myocardial infarction, Cardioprotection, Cardiology, Internal medicine and Ischemia. Derek J. Hausenloy has included themes like Inflammation and Crossover study in his Myocardial infarction study. His Cardioprotection research includes elements of Reperfusion injury, Reperfusion therapy, Mitochondrion and Ischemic preconditioning.
His Cardiology study frequently draws connections to other fields, such as Magnetic resonance imaging. While working in this field, Derek J. Hausenloy studies both Internal medicine and Perspective. His Ischemia research is multidisciplinary, relying on both Ejection fraction and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Myocardial Reperfusion Injury
Derek M Yellon;Derek J Hausenloy.
The New England Journal of Medicine (2007)
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy;Derek M. Yellon.
Journal of Clinical Investigation (2013)
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
Derek J Hausenloy;Derek M Yellon.
Cardiovascular Research (2004)
Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt Pathway
Andrew Tsang;Derek J. Hausenloy;Mihaela M. Mocanu;Derek M. Yellon.
Circulation Research (2004)
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
Sang Bing Ong;Sapna Subrayan;Shiang Y. Lim;Derek M. Yellon.
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial
Derek J Hausenloy;Peter K Mwamure;Vinod Venugopal;Joanne Harris.
The Lancet (2007)
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Derek J Hausenloy;Helen L Maddock;Gary F Baxter;Derek M Yellon.
Cardiovascular Research (2002)
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
Michel Ovize;Gary F. Baxter;Fabio Di Lisa;Péter Ferdinandy.
Cardiovascular Research (2010)
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
Derek J. Hausenloy;Derek M. Yellon.
Heart Failure Reviews (2007)
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion
Derek J. Hausenloy;A. Tsang;Mihaela M. Mocanu;Derek M. Yellon.
American Journal of Physiology-heart and Circulatory Physiology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: